A new therapeutic option for dry eye and ocular-surface conditions is now available with the recent release of DigiForm Scleral Lenses in Optimum Extra and Optimum Extreme. The product is the result of a partnership between TruForm Optics and Contamac. The materials used in the lenses maintain the lowest wetting angles in the industry, the company says, allowing patients suffering from dry-eye conditions, corneal distortion or surface irregularities to benefit. The company adds that the lens design has a forgiving lens-to-sclera relationship and provides an aqueous-hydrated environment and saline bath. They also offer an option for a lens coating, Tangible Hydra-PEG, that the company says can improve wettability, lubricity, deposit resistance and tear-film quality. For information, call (800) 792-1075.
New I-MED Product Line
A slew of newly released products from I-MED Pharma is available to help diagnose and manage dry-eye disease. First, the I-Lid ‘N Lash product line cleans and removes ocular debris and makeup to maintain lid and lash health, in addition to fighting meibomian gland dysfunction. It’s water-based and contains hydrating ingredients that soothe inflamed skin while removing makeup.
Second, I-Relief, which is a hot-and-cold therapy eye mask, can improve ocular health with consistent use over time, the company says, by increasing blood circulation and lipid oil production and reducing tear evaporation. Thermabeads within the mask help to maintain temperature and hydration while the soft cloth fabric and contouring effect aid in the comfortable fit.
Lastly, the SMTube is a quantitative way to measure tear function, which the company says is an important step in diagnosing dry-eye syndrome. The SMTube is a rapid, reliable, noninvasive product that works by absorbing tears, I-MED says. Visit imedpharma.com.
AI in Eye Care
Retina-AI says that improving patient care may have just gotten easier with the release of its new Android app, Fluid-Intelligence. The world’s first app that harnesses the power of artificial intelligence for eye-care professionals can screen for common retinal diseases, the company says. When the app is used to take a photo of an OCT scan, the image is analyzed in the cloud, where a machine-learning algorithm works to detect macular edema and subretinal fluid. AI then determines the diagnosis and generates a real-time report. In a study that compared the assessment of OCT scans by retina specialists with that made by the app, initial results found a sensitivity of 90 percent and a specificity of 82.5 percent. For information, visit retina-ai.com.